# Clinical Evaluation of the FluidVision Accommodation Intraocular Lens (AIOL)

> **NCT03508778** · NA · COMPLETED · sponsor: **PowerVision** · enrollment: 95 (actual)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** FluidVision AIOL
- **DEVICE:** AcrySof IQ PanOptix Trifocal IOL
- **PROCEDURE:** Cataract surgery

## Key facts

- **NCT ID:** NCT03508778
- **Lead sponsor:** PowerVision
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-27
- **Primary completion:** 2019-06-11
- **Final completion:** 2019-12-06
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2021-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03508778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03508778, "Clinical Evaluation of the FluidVision Accommodation Intraocular Lens (AIOL)". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03508778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*